Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis

Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer of neuroendocrine origin that has been known to recur and metastasize within the first three years of initial diagnosis. MCC is typically diagnosed with clinicopathologic correlation of a red-purple nodule or flesh colored papule on sun-damaged skin and characteristic immunohistochemical staining. We present a case of a 66-year-old White man who was found to have metastatic MCC over nine years after the initial stage one tumor was diagnosed and treated with Mohs micrographic surgery (MMS) and radiation therapy. This case highlights the importance of defining prognostic biomarkers for each patient with MCC and consideration of extended surveillance beyond the current recommended three years. Clinicians should also be attentive when counseling patients to explain that the risk of late metastasis, although low, is still possible.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-10-08
DOI
https://doi.org/10.7759/cureus.94125
Primary Topic
Polyomavirus and related diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis

Shelby L. Kubicki, Jessica Forbes Kaprive, Andrew Kwong, Daniel Rivlin et al.
Cureus
Polyomavirus and related diseases
article

Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis

Shelby L. Kubicki, Jessica Forbes Kaprive, Andrew Kwong, Daniel Rivlin, Colleen Marie Emerson
article en

Abstract

Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer of neuroendocrine origin that has been known to recur and metastasize within the first three years of initial diagnosis. MCC is typically diagnosed with clinicopathologic correlation of a red-purple nodule or flesh colored papule on sun-damaged skin and characteristic immunohistochemical staining. We present a case of a 66-year-old White man who was found to have metastatic MCC over nine years after the initial stage one tumor was diagnosed and treated with Mohs micrographic surgery (MMS) and radiation therapy. This case highlights the importance of defining prognostic biomarkers for each patient with MCC and consideration of extended surveillance beyond the current recommended three years. Clinicians should also be attentive when counseling patients to explain that the risk of late metastasis, although low, is still possible.

CureusVol. 17(10)
LewisGale Hospital Montgomery (US), Larkin Community Hospital (US), University of Houston (US), Indiana University (US)
Openalex Percentile: Top 61%
Polyomavirus and related diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.